Experienced in Marginal Zone Lymphoma (MZL)

Dr. Neeta D. Pandit-Taskar

Nuclear Medicine
UPMC
University Of Pittsburgh Physicians
1400 Locust St, Suite 3206, 
Pittsburgh, PA 
Experienced in Marginal Zone Lymphoma (MZL)
UPMC
University Of Pittsburgh Physicians
1400 Locust St, Suite 3206, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Neeta Pandit-Taskar is a Nuclear Medicine provider in Pittsburgh, Pennsylvania. Dr. Pandit-Taskar is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Melorheostosis, Melorheostosis with Osteopoikilosis, Osteopenia, and Gastroesophageal Junction Cancer.

Her clinical research consists of co-authoring 151 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Nuclear Medicine
Licenses
Nuclear Medicine in PA
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Indiana Regional Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

UNIVERSITY OF PITTSBURGH PHYSICIANS
1400 Locust St, Suite 3206, Pittsburgh, PA 15219
Call: 412-232-8276
Other Locations
UNIVERSITY OF PITTSBURGH PHYSICIANS
5230 Centre Ave, Suite 509, Pittsburgh, PA 15232
Call: 412-623-2458
UNIVERSITY OF PITTSBURGH PHYSICIANS
9100 Babcock Blvd, Pittsburgh, PA 15237
Call: 412-367-6700
UNIVERSITY OF PITTSBURGH PHYSICIANS
300 Halket St, Pittsburgh, PA 15213
UNIVERSITY OF PITTSBURGH PHYSICIANS
200 Lothrop St, Pittsburgh, PA 15213

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma: A Multi-center, Dose-escalation, Open-label, Non-randomized, Phase 1-2a Theranostic Clinical Trial
67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma: A Multi-center, Dose-escalation, Open-label, Non-randomized, Phase 1-2a Theranostic Clinical Trial
Enrollment Status: Terminated
Publish Date: September 16, 2025
Intervention Type: Drug
Study Drugs: 67Cu-SARTATE, 64Cu-SARTATE
Study Phase: Phase 1/Phase 2
A Phase I/IIA Study of 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
A Phase I/IIA Study of 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Radiation, Other, Device
Study Phase: Phase 1/Phase 2
Pilot Trial of PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Pilot Trial of PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Enrollment Status: Completed
Publish Date: December 10, 2024
Intervention Type: Radiation, Device
Study Phase: Not Applicable
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Diagnostic test
Study Phase: Phase 3
Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (^90Y-DOTA-cG250) in Patients With Advanced Renal Cancer
Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (^90Y-DOTA-cG250) in Patients With Advanced Renal Cancer
Enrollment Status: Completed
Publish Date: October 10, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase I Study of Positron Emission Tomography (PET/CT) With ⁸⁹Zr-Df-IAB22M2C in Patients With Selected Solid Malignancies (Non Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Squamous Cell Carcinoma Head and Neck (SqCCHN), Melanoma, Merkel Cell Tumor, Renal, Bladder, Hepatocellular, Triple Negative Breast, or Gastroesophageal Cancer) or Hodgkin's Lymphoma
A Phase I Study of Positron Emission Tomography (PET/CT) With ⁸⁹Zr-Df-IAB22M2C in Patients With Selected Solid Malignancies (Non Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Squamous Cell Carcinoma Head and Neck (SqCCHN), Melanoma, Merkel Cell Tumor, Renal, Bladder, Hepatocellular, Triple Negative Breast, or Gastroesophageal Cancer) or Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: September 18, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

149 Total Publications

Pediatric PET/MRI: Imaging Techniques, Indications, and Clinical Implementation.
Pediatric PET/MRI: Imaging Techniques, Indications, and Clinical Implementation.
Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: October 16, 2025
View All 149 Publications
Similar Doctors
Advanced in Marginal Zone Lymphoma (MZL)
Dr. Jitesh Dhingra
Nuclear Medicine | Radiology
Advanced in Marginal Zone Lymphoma (MZL)
Dr. Jitesh Dhingra
Nuclear Medicine | Radiology

Allegheny Clinic Radiology

100 S Jackson Ave, 
Pittsburgh, PA 
 (5.6 miles away)
412-734-6015
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jitesh Dhingra is a Nuclear Medicine specialist and a Radiologist in Pittsburgh, Pennsylvania. Dr. Dhingra is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Osteopenia, Melorheostosis with Osteopoikilosis, Melorheostosis, and Gastroesophageal Junction Cancer.

VIEW MORE MARGINAL ZONE LYMPHOMA (MZL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pandit-Taskar's expertise for a condition
ConditionClose
      • Advanced
      • Gastroesophageal Junction Cancer
        Dr. Pandit-Taskar is
        Advanced
        . Learn about Gastroesophageal Junction Cancer.
        See more Gastroesophageal Junction Cancer experts
      • Melorheostosis
        Dr. Pandit-Taskar is
        Advanced
        . Learn about Melorheostosis.
        See more Melorheostosis experts
      • Melorheostosis with Osteopoikilosis
        Dr. Pandit-Taskar is
        Advanced
        . Learn about Melorheostosis with Osteopoikilosis.
        See more Melorheostosis with Osteopoikilosis experts
      • Osteopenia
        Dr. Pandit-Taskar is
        Advanced
        . Learn about Osteopenia.
        See more Osteopenia experts
      • Experienced
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Pandit-Taskar is
        Experienced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Classical Hodgkin Lymphoma
        Dr. Pandit-Taskar is
        Experienced
        . Learn about Classical Hodgkin Lymphoma.
        See more Classical Hodgkin Lymphoma experts
      • Marginal Zone Lymphoma (MZL)
        Dr. Pandit-Taskar is
        Experienced
        . Learn about Marginal Zone Lymphoma (MZL).
        See more Marginal Zone Lymphoma (MZL) experts
      • Muscle Invasive Bladder Cancer
        Dr. Pandit-Taskar is
        Experienced
        . Learn about Muscle Invasive Bladder Cancer.
        See more Muscle Invasive Bladder Cancer experts
      • Non-Muscle Invasive Bladder Cancer
        Dr. Pandit-Taskar is
        Experienced
        . Learn about Non-Muscle Invasive Bladder Cancer.
        See more Non-Muscle Invasive Bladder Cancer experts
      • Smoldering Multiple Myeloma
        Dr. Pandit-Taskar is
        Experienced
        . Learn about Smoldering Multiple Myeloma.
        See more Smoldering Multiple Myeloma experts
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                    0 / 1000
                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.